Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 136 | 15,773 | -73,003 | -40,133 | -113,724 |
| Depreciation Amortization | 6,881 | 5,796 | 3,929 | 2,024 | 7,146 |
| Accounts receivable | -2,068 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,940 | 1,222 | 1,184 | 1,594 | -11,578 |
| Other Working Capital | -65,509 | -35,383 | -25,790 | -9,153 | -58,977 |
| Other Operating Activity | -85,109 | -97,135 | 18,633 | 10,432 | 59,779 |
| Operating Cash Flow | $-148,609 | $-109,727 | $-75,047 | $-35,236 | $-117,354 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -380 | -290 | -161 | -62 | -7,975 |
| Net Acquisitions | 141,272 | 141,272 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -4,426 |
| Sale Of Investment | 1,401 | N/A | 1,401 | N/A | 22,983 |
| Other Investing Activity | 0 | 1,401 | 0 | 0 | 0 |
| Investing Cash Flow | $142,293 | $142,383 | $1,240 | $-62 | $10,582 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 13,516 | N/A | N/A | 103,378 |
| Debt Repayment | -127,905 | -127,905 | N/A | N/A | -52,860 |
| Common Stock Issued | 24,017 | 22,280 | 18,762 | 18,762 | 21,187 |
| Other Financing Activity | 13,516 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-90,372 | $-92,109 | $18,762 | $18,762 | $71,705 |
| Exchange Rate Effect | -1 | N/A | N/A | N/A | 2 |
| Beginning Cash Position | 136,150 | 136,150 | 136,150 | 136,150 | 171,215 |
| End Cash Position | 39,461 | 76,697 | 81,105 | 119,614 | 136,150 |
| Net Cash Flow | $-96,689 | $-59,453 | $-55,045 | $-16,536 | $-35,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -148,609 | -109,727 | -75,047 | -35,236 | -117,354 |
| Capital Expenditure | -380 | -290 | -161 | -62 | -7,975 |
| Free Cash Flow | -148,989 | -110,017 | -75,208 | -35,298 | -125,329 |